Open Letter

An Open Letter To Our Customers

January 9, 2017

As you may have heard, Quincy Bioscience is defending itself against unproven claims that Prevagen does not work as advertised. We firmly contend that these allegations are not true, and we intend to vigorously defend ourselves in court. There are a few important things for you to understand.

First, Prevagen is safe. The FTC is not alleging that Prevagen can cause harm to anyone who takes it. The sole dispute rests on the interpretation and analysis of clinical trial data on memory and cognition, with the FTC attempting to hold the company to a standard that is unreasonable, scientifically debatable, and legally invalid.

Second, Prevagen works. There exists a large body of evidence demonstrating that Prevagen improves memory and supports healthy brain function. This evidence includes Quincy’s main clinical study, which meets the government’s own definition of “gold standard.”

If you have any questions about this case, please let us know. You can email us at answers@prevagen.com.

Thank you for your business and your loyalty.
Sincerely,

Quincy Bioscience


Click to
Scroll